Home/Filings/4/0001215911-05-000001
4//SEC Filing

TOWNSEN FULTON DUWAINE 4

Accession 0001215911-05-000001

CIK 0001013351other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 2:15 PM ET

Size

5.7 KB

Accession

0001215911-05-000001

Insider Transaction Report

Form 4
Period: 2005-02-18
Transactions
  • Award

    Option to Purchase

    2005-02-18$1.64/sh+20,000$32,80020,000 total
    Exercise: $1.64From: 2005-09-30Exp: 2015-02-18Common stock (20,000 underlying)
Footnotes (1)
  • [F1]Vesting contigent upon participation in at least 75% of Board Meeting during the year ended Sept., 30, 2005

Issuer

MAXIM PHARMACEUTICALS INC

CIK 0001013351

Entity typeother

Related Parties

1
  • filerCIK 0001215911

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 2:15 PM ET
Size
5.7 KB